Sandeep Dixit

Just a couple. Actually, one question on margins. We have seen a massive spurt in these margins over the last 12 to 18 months. Is this sustainable going forward? Or is it the new of Natco Pharma?

I understand that. But I mean, let me look at these numbers. They have gon e from 29% in FY '21 to 33% to 43% now. So, obviously, product mixes don't change quarterly or whatever. I presume they change reasonably over, let's say, a few years. So, should we say that these are the kind of margins which we can look for over the next year or 2?

And then, I mean, if you are talking about a 15%, 20% top line growth, stable margins, isn't your 20% profit growth a little conservative?